Nutex Health
NUTX
119 hedge funds and large institutions have $435M invested in Nutex Health in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 10 closing their positions.
230% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 10
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
126% more capital inflows, than outflows
Capital inflows: $57.1M | Capital outflows: $25.2M
24% more funds holding
Funds holding: 96 → 119 (+23)
3% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 34
6.04% less ownership
Funds ownership: 43.41% → 37.36% (-6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Topline Capital Management
Santa Monica,
California
|
+$15.8M |
| 2 |
Pertento Partners
London,
United Kingdom
|
+$7.16M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.81M |
| 4 |
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$2.79M |
| 5 |
BlackRock
New York
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$8.38M |
| 2 |
Millennium Management
New York
|
-$2.53M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.83M |
| 4 |
Jane Street
New York
|
-$1.36M |
| 5 |
Goldman Sachs
New York
|
-$1.35M |
NUTX Hedge Fund Activity: Q4 2025 in Review
119 of the 8,306 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q4 2025, worth a combined $435M — up 75% from $249M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new NUTX positions and 10 closed out — a net gain of 23 holders — while 35 added to existing stakes and 34 trimmed.
The largest buyer was Topline Capital Management, adding an estimated $15.8M. The largest seller was Morgan Stanley, cutting an estimated $8.38M.
- 119 institutional investors held Nutex Health (NUTX) as of Q4 2025, up from 96 in Q3 2025.
- Funds reported $435M of Nutex Health stock for Q4 2025, up 75% quarter-over-quarter.
- 33 funds opened new Nutex Health positions in Q4 2025 and 10 closed out, a net change of +23 holders.
- The largest Nutex Health buyer in Q4 2025 was Topline Capital Management, an estimated $15.8M added.
- The largest Nutex Health seller in Q4 2025 was Morgan Stanley, an estimated $8.38M sold.
Based on aggregated 13F filings for Q4 2025.